BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 26021680)

  • 1. Clinical Value of (18)F-FDG- PET-CT in the Preoperative Staging of Peritoneal Carcinomatosis from Colorectal Origin.
    De Vos N; Goethals I; Ceelen W
    Acta Chir Belg; 2014; 114(6):370-5. PubMed ID: 26021680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.
    Klumpp B; Schwenzer NF; Gatidis S; Koenigsrainer I; Koenigsrainer A; Beckert S; Mueller M; Claussen CD; Pfannenberg C
    Rofo; 2014 Apr; 186(4):359-66. PubMed ID: 24683168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pitfalls and mimickers on (18)F-FDG-PET/CT in peritoneal carcinomatosis from colorectal cancer: An analysis from 37 patients.
    Audollent R; Eveno C; Dohan A; Sarda L; Jouvin I; Soyer P; Pocard M
    J Visc Surg; 2015 Nov; 152(5):285-91. PubMed ID: 26115889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response.
    Liberale G; Lecocq C; Garcia C; Muylle K; Covas A; Deleporte A; Hendlisz A; Bouazza F; El Nakadi I; Flamen P
    Anticancer Res; 2017 Feb; 37(2):929-934. PubMed ID: 28179354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can [
    Elekonawo FMK; Starremans B; Laurens ST; Bremers AJA; de Wilt JHW; Heijmen L; de Geus-Oei LF
    Abdom Radiol (NY); 2020 Feb; 45(2):301-306. PubMed ID: 31642963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
    Lopez-Lopez V; Cascales-Campos PA; Gil J; Frutos L; Andrade RJ; Fuster-Quiñonero M; Feliciangeli E; Gil E; Parrilla P
    Eur J Radiol; 2016 Oct; 85(10):1824-1828. PubMed ID: 27666623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Pfannenberg C; Königsrainer I; Aschoff P; Oksüz MO; Zieker D; Beckert S; Symons S; Nieselt K; Glatzle J; Weyhern CV; Brücher BL; Claussen CD; Königsrainer A
    Ann Surg Oncol; 2009 May; 16(5):1295-303. PubMed ID: 19252950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative assessment of peritoneal carcinomatosis in patients undergoing hyperthermic intraperitoneal chemotherapy following cytoreductive surgery.
    Pasqual EM; Bertozzi S; Bacchetti S; Londero AP; Basso SM; Santeufemia DA; Lo Re G; Lumachi F
    Anticancer Res; 2014 May; 34(5):2363-8. PubMed ID: 24778044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
    Sasaki K; Kawasaki H; Sato M; Koyama K; Yoshimi F; Nagai H
    Dig Surg; 2017; 34(1):60-67. PubMed ID: 27454870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
    Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases.
    Dresen RC; De Vuysere S; De Keyzer F; Van Cutsem E; Prenen H; Vanslembrouck R; De Hertogh G; Wolthuis A; D'Hoore A; Vandecaveye V
    Cancer Imaging; 2019 Jan; 19(1):1. PubMed ID: 30616608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (18)F-FDG PET/CT, cytoreductive surgery and intraperitoneal chemohyperthermia for the therapeutic management in peritoneal carcinomatosis: A pilot study.
    Cistaro A; Cucinotta M; Cassalia L; Priola A; Priola S; Pappalardo M; Coppolino P; De Simone M; Quartuccio N
    Rev Esp Med Nucl Imagen Mol; 2016; 35(4):232-7. PubMed ID: 26907833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of contrast-enhanced CT combined with 18-FDG PET in patients selected for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Sommariva A; Evangelista L; Pintacuda G; Cervino AR; Ramondo G; Rossi CR
    Abdom Radiol (NY); 2018 May; 43(5):1094-1100. PubMed ID: 28770289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI.
    Klumpp BD; Schwenzer N; Aschoff P; Miller S; Kramer U; Claussen CD; Bruecher B; Koenigsrainer A; Pfannenberg C
    Abdom Imaging; 2013 Feb; 38(1):64-71. PubMed ID: 22476333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
    Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
    J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomyxoma peritonei: role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction.
    Passot G; Glehen O; Pellet O; Isaac S; Tychyj C; Mohamed F; Giammarile F; Gilly FN; Cotte E
    Eur J Surg Oncol; 2010 Mar; 36(3):315-23. PubMed ID: 19818580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making.
    Kantorová I; Lipská L; Bêlohlávek O; Visokai V; Trubaĉ M; Schneiderová M
    J Nucl Med; 2003 Nov; 44(11):1784-8. PubMed ID: 14602860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative CT-based predictive factors for resectability and medium-term overall survival in patients with peritoneal carcinomatosis from colorectal cancer.
    Suzuki C; Wallgren H; Abraham-Nordling M; Palmer G
    Clin Radiol; 2018 Aug; 73(8):756.e11-756.e16. PubMed ID: 29678273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
    Briggs RH; Chowdhury FU; Lodge JP; Scarsbrook AF
    Clin Radiol; 2011 Dec; 66(12):1167-74. PubMed ID: 21867996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT.
    Dromain C; Leboulleux S; Auperin A; Goere D; Malka D; Lumbroso J; Schumberger M; Sigal R; Elias D
    Abdom Imaging; 2008; 33(1):87-93. PubMed ID: 17632751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.